SUNPHARMACEUTICALS

SUN PHARMACEUTICALS is a manufacturer.

Enterprise Introduction:

Sun Pharmaceutical Industries Ltd. is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra, India. It is the largest pharmaceutical company in India and the fourth largest specialty generics company in the world. Sun Pharma manufactures and markets a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs), primarily in India and the United States, as well as in other markets globally.

The company focuses on a variety of therapeutic areas including psychiatry, neurology, cardiology, diabetology, gastroenterology, ophthalmology, and dermatology. Sun Pharma is known for its strong research and development capabilities, which drive its innovation in both generic and specialty products. With a presence in over 100 countries and a significant number of manufacturing facilities across different continents, Sun Pharma has established itself as a global leader in the pharmaceutical industry. Its operations encompass the entire value chain from drug discovery and development to manufacturing and marketing.

Here are some of the products manufactured or marketed by Sun Pharmaceutical Industries Ltd. of India:

* **Branded Generics:**

* Voriconazole

* Levetiracetam

* Irbesartan

* Pantoprazole

* Rabeprazole

* Tramadol

* Gliclazide

* Metformin

* Modafinil

* Clonazepam

* **Specialty Products:**

* Absorica (Isotretinoin)

* Cequa (Cyclosporine)

* Levulan (Aminolevulinic Acid)

* Odomzo (Sonidegib)

* Winlevi (Clascoterone)

* Ilumya (Tildrakizumab)

* **Active Pharmaceutical Ingredients (APIs):**

* A wide range of APIs across various therapeutic categories.

Please note this list is not exhaustive, and Sun Pharma has a diverse and extensive portfolio of pharmaceutical products. For the most up-to-date and comprehensive information, please refer to the official Sun Pharmaceutical Industries Ltd. website.